- Explore how patient-centric supply planning can reduce burden, improve retention, and build trust through advocacy partnerships, flexible logistics, and aligned operations
Archives: Agenda
VIRTUAL REGULATORY SPOTLIGHT: Understanding duty and entry rates in US clinical supply chain imports!
- Optimize clinical trade compliance by ensuring precise material classification and valuation
- Collaborating with brokers and logistics partners to ensure compliant, efficient
importation - Determining duty rates and entry rates for different types of clinical trial materials and products
- Applying for duty exemptions: are you eligible?
ENHANCING COMPLICANCE, QUALITY & PARTNERSHIPS
INTERACTIVE BOARDROOM: COLLABORATE, SOLVE, SHARE š¤
AI is powerful, but the drug and the patientĀ comeĀ first.Ā This boardroom explores how teams canĀ leverageĀ AI safely, integrate it into workflows, andĀ maintainĀ human control with strong processes.
Shift from “random prompting” to building Structured Supply Chain AI Workflows that save hours while keeping human oversight and data security intact
Outcome:Ā Each table will collaborate to createĀ practicalĀ strategies,Ā and governance approaches that balance AI capabilities with human oversight, ensuring AI enhances decisions rather than replacing critical thinking.
END-TO-END SUPPLY EXCELLENCE
AI with a Human Touch: Practical Strategies for Smart, Safe Adoption
CASE STUDY: The 72-Hour Pulse: How Orca Bio is Using AI to Limit Risk and Supporting Patient Delivery
š LIVE POLL
- How to safeguard temperature-sensitive biologics and advanced therapies during shipping delays
- How to stay compliant with local and global regulations while maintaining chain-custody
- How to select validated storage facilities for all temperature ranges while keeping inventory visible and minimizing loss
ASK THE EXPERT PANEL: How to choose CDMOs as a true extension of your team to enable flexible, and stage-specific clinical supply needs š LIVE POLL
- How to align CDMO partnerships with phase-specific needs while staying agile
- How to collaborate across CDMOs and ensure smooth tech transitions, especially forĀ biologics therapies
- How to build transparent CDMO partnerships from Day 1 to overcome challenges and save costs
Moderator: Amanda Murphy, Head of Digital Product Management, GlobalData
- Panelist 1: Aimee Hogue, Director Supply Chain, Sutro Biopharma
- Panelist 2: Amber Bill, Associate Director, Sangamo TherapeuticsĀ Ā
Panelist 3: Burkard Kolb, Former Executive Director, CMC Operations, 89bioĀ (Genentech)Ā
ENHANCING STRATEGIC PARTNERSHIPS
CASE STUDY: Streamlining E2E Supply Complexity: Implementing Robust S&OP Governance Across the Value Chain
- Aligning Supply Chain, CMC, Clinical Operations, Regulatory, Quality, and Finance to evaluate options, trade-offs, risk, and cost and align on an integrated path forward
- Establishing S&OP governance, ownership, and decision rights linking supply execution with financial planning to drive transparency, accountability, and aligned decisions
- Creating end-to-end visibility to identify constraints early, improve agility, mitigate risk, and maintain supply continuity across clinical and commercial programs